Please assess the completion status of the following clinical trial:

Trial Title: Study Of Continuous Use Of Celecoxib Vs. Usual or Intermittent Use

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has been diagnosed, according to American College of Rheumatology guidelines, with osteoarthritis of the hip or knee and requires non-steroidal anti-inflammatory drugs (NSAIDs) to control their osteoarthritis pain and have access to a touch-tone telephone.~Exclusion Criteria:~* Subject has had surgery on index joint.~* Subject has history of rheumatoid arthritis or fibromyalgia syndrome.~* Subject has active gastrointestinal or cardiovascular disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Celecoxib - Continuous use (Type: ACTIVE_COMPARATOR): None
- Celecoxib - Intermittent use (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).